Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells $408,300.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00. Following the sale, the president now directly owns 1,606,097 shares in the company, valued at approximately $21,858,980.17. The trade was a 1.83 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, November 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $11.35, for a total transaction of $340,500.00.

Alignment Healthcare Trading Up 0.2 %

ALHC stock traded up $0.03 during trading on Friday, hitting $14.58. The company had a trading volume of 1,873,020 shares, compared to its average volume of 1,888,102. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $14.79. The company has a 50 day simple moving average of $11.92 and a 200-day simple moving average of $10.71. The firm has a market capitalization of $2.79 billion, a P/E ratio of -18.94 and a beta of 1.45. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, hitting analysts’ consensus estimates of ($0.14). The business had revenue of $692.43 million for the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company’s quarterly revenue was up 51.6% compared to the same quarter last year. During the same period last year, the company posted ($0.19) earnings per share. As a group, research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have weighed in on ALHC. UBS Group boosted their price objective on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Stifel Nicolaus boosted their target price on Alignment Healthcare from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday. Stephens restated an “overweight” rating and issued a $17.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 2nd. Barclays boosted their price objective on shares of Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. Finally, KeyCorp began coverage on shares of Alignment Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, two have given a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $11.88.

Institutional Investors Weigh In On Alignment Healthcare

Several hedge funds have recently made changes to their positions in the company. Deerfield Management Company L.P. Series C lifted its stake in Alignment Healthcare by 31.8% in the second quarter. Deerfield Management Company L.P. Series C now owns 10,901,485 shares of the company’s stock worth $85,250,000 after acquiring an additional 2,630,788 shares during the period. Hood River Capital Management LLC lifted its holdings in Alignment Healthcare by 6.4% during the second quarter. Hood River Capital Management LLC now owns 3,106,690 shares of the company’s stock worth $24,294,000 after buying an additional 185,854 shares during the period. Geode Capital Management LLC boosted its position in Alignment Healthcare by 1.4% during the 3rd quarter. Geode Capital Management LLC now owns 2,442,447 shares of the company’s stock valued at $28,875,000 after acquiring an additional 32,839 shares in the last quarter. State Street Corp increased its holdings in shares of Alignment Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 2,252,287 shares of the company’s stock valued at $26,622,000 after acquiring an additional 20,731 shares during the period. Finally, Renaissance Technologies LLC increased its holdings in shares of Alignment Healthcare by 16.8% in the 2nd quarter. Renaissance Technologies LLC now owns 1,565,800 shares of the company’s stock valued at $12,245,000 after acquiring an additional 225,000 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.